Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences has submitted a routine regulatory certificate to BSE for the quarter ended 31st March 2025, as required under SEBI's Depositories and Participants Regulations, 2018. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), Purva Sharegistry (India) Pvt. Ltd., confirming that all share certificates received for dematerialization during the quarter were processed and confirmed to the depositories within the prescribed timelines. During Q4 FY25, only two shareholders dematerialized a total of 600 shares (100 shares by Amishkumar B Shah and 500 shares by Oommen Abraham). The filing is signed by Siddhi Shah, Company Secretary, and dated 3rd April 2025.
This is a routine procedural compliance filing with no material impact on the business or shareholders. The very low dematerialization activity (600 shares) suggests no significant change in shareholding structure during the quarter. Retail investors should view this as standard housekeeping and not a signal of any corporate action.